Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 2/20 | 0.59 |
| ▸ | HCRTR2 | O43614 | 2/20 | 0.59 |
| ▸ | GSK3B | P49841 | 14/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | CDK2 | P24941 | 1/20 | 0.39 |
| ▸ | CDK16 | Q00536 | 1/20 | 0.39 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2012866 | 1.00 | HCRTR1 (0.59) | HCRTR1HCRTR2GSK3BSMN1; SMN2NPC1 | |
| SCHEMBL2015628 | 0.90 | HCRTR1 (0.57) | HCRTR1HCRTR2GSK3BSMN1; SMN2NPC1 | |
| SCHEMBL2013812 | 0.89 | HCRTR1 (0.59) | HCRTR1HCRTR2SMN1; SMN2NPC1RAB9A | |
| SCHEMBL2015054 | 0.84 | HCRTR1 (0.60) | HCRTR1HCRTR2NPC1RAB9AKDM4E | |
| SCHEMBL13139074 | 0.82 | HCRTR1 (0.84) | HCRTR1HCRTR2SMN1; SMN2NPC1RAB9A | |
| SCHEMBL13139077 | 0.82 | HCRTR1 (0.75) | HCRTR1HCRTR2NPC1RAB9AMAPT | |
| SCHEMBL2018296 | 0.82 | HCRTR1 (0.65) | HCRTR1HCRTR2NPC1RAB9A | |
| SCHEMBL2016380 | 0.82 | HCRTR1 (0.65) | HCRTR1HCRTR2NPC1RAB9A | |
| SCHEMBL2010990 | 0.81 | HCRTR1 (0.58) | HCRTR1HCRTR2NPC1RAB9AKDM4E | |
| SCHEMBL2011939 | 0.81 | HCRTR1 (0.58) | HCRTR1HCRTR2NPC1RAB9AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011073316-A1 | 4-ARYL-BUTANE-1,3-DIAMIDES | NOVARTIS AG (CH) | 2011-06-23 | — | — | WO | disclosed |